Work

Tolerability of 5 mg Solifenacin Once Daily Versus 5 mg Oxybutynin Immediate Release 3 Times Daily: Results of the VECTOR Trial

Year: 2010

Type: article

Study designs: Randomized Controlled Trial, Clinical Trial

Source: The Journal of Urology

DOI: 10.1016/j.juro.2010.01.012

Authors: Sender Herschorn, Lynn Stothers, Kevin Carlson, Blair Egerdie, Jerzy B. Gajewski, Peter Pommerville, Jane Schulz, Sidney Radomski, Harold Drutz, Jack Barkin, Fran Paradiso-Hardy

Institutions: University of Toronto, University of British Columbia, University of Calgary, Dalhousie University, University of Alberta, Royal Alexandra Hospital, Astellas Pharma (Canada)

Language: English

Topic: Urinary Bladder and Prostate Research

Subfield: Urology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2005286581

FWCI: 6.778

Cites: 26

Cited by: 49

Related to: 10